IR@PKUHSC  > 北京大学第一临床医学院
学科主题临床医学
Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis
Huang, Yuanshen1,2,3,4; Litvinov, Ivan V.5; Wang, Yang6; Su, Ming-Wan1,2,3; Tu, Ping6; Jiang, Xiaoyan4; Kupper, Thomas S.7; Dutz, Jan P.3,8; Sasseville, Denis5; Zhou, Youwen1,2,3,8
关键词TOX mycosis fungoides cutaneous T cell lymphoma marker prognostic factor
刊名ONCOTARGET
2014-06-01
5期:12页:4418-4425
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology ; Cell Biology
研究领域[WOS]Oncology ; Cell Biology
关键词[WOS]T-CELL LYMPHOMA ; SEZARY-SYNDROME ; MARKERS ; BCL7A
英文摘要

Mycosis fungoides (MF) often mimics the common chronic inflammatory skin diseases and is difficult to be diagnosed with certainty, partly because of the lack of well-characterized molecular markers. Previously, we discovered that TOX, a key T cell development regulator, was aberrantly over-expressed in early stage MF. In the current multi-center study involving two independent patient cohorts, we determined the prevalence of TOX over-expression in the full spectrum of MF skin biopsies, and tested if TOX expression levels correlated with long term clinical outcomes. We examined TOX expression levels in 113 MF biopsies. We found that the MF biopsies expressed higher TOX mRNA than the controls in both cohorts (17.9 fold in cohort 1, P = 0.002; 5.8 fold in cohort 2, P < 0.0001). In addition, thicker skin lesions such as plaques and tumors expressed even higher TOX levels than thinner patches. Further, TOX over-expression differentiated MF from the controls (area under the curve [AUC]= 0.87, P < 0.0001). Finally, high TOX mRNA levels correlated with increased risks of disease progression (P = 0.003) and disease-specific mortality (P = 0.008). In conclusion, TOX may be a useful marker for improving MF diagnosis and prognostication.

语种英语
WOS记录号WOS:000339055200037
项目编号81072233 ; 81201228
资助机构Canadian Institutes of Health Research ; Canadian Dermatology Foundation ; Fonds de la recherche en sante du Quebec (FRSQ) ; National Natural Science Foundation of China
引用统计
被引频次:18[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67009
专题北京大学第一临床医学院
北京大学第一临床医学院_皮肤性病科
作者单位1.McGill Univ, Ctr Hlth, Div Dermatol, Montreal, PQ, Canada
2.Vancouver Coastal Hlth Res Inst, Mol Med Lab, Vancouver, BC, Canada
3.Vancouver Coastal Hlth Res Inst, Chieng Genom Ctr, Vancouver, BC, Canada
4.British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
5.Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada
6.Peking Univ, Hosp 1, Dept Dermatol & Venereol, Beijing 100871, Peoples R China
7.Harvard Univ, Brigham & Womens Hosp, Dept Dermatol, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA
8.British Columbia Canc Agcy, Dermatol Oncol Program, Vancouver, BC V5Z 4E6, Canada
推荐引用方式
GB/T 7714
Huang, Yuanshen,Litvinov, Ivan V.,Wang, Yang,et al. Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis[J]. ONCOTARGET,2014,5(12):4418-4425.
APA Huang, Yuanshen.,Litvinov, Ivan V..,Wang, Yang.,Su, Ming-Wan.,Tu, Ping.,...&Zhou, Youwen.(2014).Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis.ONCOTARGET,5(12),4418-4425.
MLA Huang, Yuanshen,et al."Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis".ONCOTARGET 5.12(2014):4418-4425.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Huang, Yuanshen]的文章
[Litvinov, Ivan V.]的文章
[Wang, Yang]的文章
百度学术
百度学术中相似的文章
[Huang, Yuanshen]的文章
[Litvinov, Ivan V.]的文章
[Wang, Yang]的文章
必应学术
必应学术中相似的文章
[Huang, Yuanshen]的文章
[Litvinov, Ivan V.]的文章
[Wang, Yang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。